Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer

Neuropilin-2 (NRP2) is a prognostic indicator for reduced survival in bladder cancer (BCa) patients. Together with its major ligand, vascular endothelial growth factor (VEGF)-C, NRP2 expression is a predictive factor for treatment outcome in response to radiochemotherapy in BCa patients who underwen...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Schulz, Alexander, Gorodetska, Ielizaveta, Behrendt, Rayk, Fuessel, Susanne, Erdmann, Kati, Foerster, Sarah, Datta, Kaustubh, Mayr, Thomas, Dubrovska, Anna, Muders, Michael H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2020
Aiheet:
Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986262/
https://ncbi.nlm.nih.gov/pubmed/32038994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01461
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia